metforminPapers
Papers about metformin
- papers
- 3,984
Newest first
3,151 to 3,200 of 3,984Every paper here, unless its row says otherwiseIndexed under metformin in PubMed's chemical list; returned by a PubMed search for metformin
Effect of simvastatin and fenofibrate on cytokine release and systemic inflammation in type 2 diabetes mellitus with mixed dyslipidemia.
The American journal of cardiology2011PMID 21276586Indexed under metformin in PubMed's chemical list
Metformin for olanzapine-induced weight gain: a systematic review and meta-analysis.
British journal of clinical pharmacology2011PMID 21284696
Exenatide twice daily versus premixed insulin aspart 70/30 in metformin-treated patients with type 2 diabetes: a randomized 26-week study on glycemic control and hypoglycemia.
Diabetes care2011PMID 21285388
Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin.
Journal of Alzheimer's disease2011PMID 21297276
Liraglutide improves treatment satisfaction in people with Type 2 diabetes compared with sitagliptin, each as an add on to metformin.
Diabetic medicine2011PMID 21309842
Saxagliptin, a potent, selective inhibitor of DPP-4, does not alter the pharmacokinetics of three oral antidiabetic drugs (metformin, glyburide or pioglitazone) in healthy subjects.
Diabetes, obesity & metabolism2011PMID 21332626
Initial combination therapy with saxagliptin and metformin provides sustained glycaemic control and is well tolerated for up to 76 weeks.
Diabetes, obesity & metabolism2011PMID 21342412
One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel-group, open-label trial.
International journal of clinical practice2011PMID 21355967
In vitro and in vivo effects of metformin on human adipose tissue adiponectin.
Obesity facts2011PMID 21372608
Patient-reported outcomes are superior in patients with Type 2 diabetes treated with liraglutide as compared with exenatide, when added to metformin, sulphonylurea or both: results from a randomized, open-label study.
Diabetic medicine2011PMID 21388442Returned by a PubMed search for metformin
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor PF-734200 added to metformin in Type 2 diabetes.
Diabetic medicine2011PMID 21392067
The effect of initial therapy with the fixed-dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus.
Diabetes, obesity & metabolism2011PMID 21410627
Treatment with insulin sensitizer metformin improves arterial properties, metabolic parameters, and liver function in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled trial.
Metabolism: clinical and experimental2011PMID 21411114
Effects of rosiglitazone, glyburide, and metformin on β-cell function and insulin sensitivity in ADOPT.
Diabetes2011PMID 21415383
A systematic review of metformin to limit weight-gain with atypical antipsychotics.
Journal of clinical pharmacy and therapeutics2011PMID 21418264
The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus.
Acta diabetologica2011PMID 21424914
DURATION-2: efficacy and safety of switching from maximum daily sitagliptin or pioglitazone to once-weekly exenatide.
Diabetic medicine2011PMID 21434995Indexed under metformin in PubMed's chemical list
Renal function in type 2 diabetes with rosiglitazone, metformin, and glyburide monotherapy.
Clinical journal of the American Society of Nephrology2011PMID 21454723
AMP-activated protein kinase is activated in adipose tissue of individuals with type 2 diabetes treated with metformin: a randomised glycaemia-controlled crossover study.
Diabetologia2011PMID 21455728
PIOfix-study: effects of pioglitazone/metformin fixed combination in comparison with a combination of metformin with glimepiride on diabetic dyslipidemia.
Diabetes technology & therapeutics2011PMID 21457065
Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression.
Chemico-biological interactions2011PMID 21457706
AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice.
Cell metabolism2011PMID 21459323
Metformin is a reasonable first-line treatment option for non-obese women with infertility related to anovulatory polycystic ovary syndrome--a meta-analysis of randomised trials.
The Australian & New Zealand journal of obstetrics & gynaecology2011PMID 21466513
A Dose-Ranging Study of the DPP-IV Inhibitor PF-734200 Added to Metformin in Subjects With Type 2 Diabetes*.
Experimental and clinical endocrinology & diabetes2011PMID 21472661
Effects of metformin and pioglitazone on serum pentosidine levels in type 2 diabetes mellitus.
Experimental and clinical endocrinology & diabetes2011PMID 21472665
Triple oral fixed-dose diabetes polypill versus insulin plus metformin efficacy demonstration study in the treatment of advanced type 2 diabetes (TrIED study-II).
Diabetes, obesity & metabolism2011PMID 21477065
Sitagliptin more effectively achieves a composite endpoint for A1C reduction, lack of hypoglycemia and no body weight gain compared with glipizide.
Diabetes research and clinical practice2011PMID 21477878Indexed under metformin in PubMed's chemical list
An analysis of early insulin glargine added to metformin with or without sulfonylurea: impact on glycaemic control and hypoglycaemia.
Diabetes, obesity & metabolism2011PMID 21481127
The effects of metformin or orlistat on obese women with polycystic ovary syndrome: a prospective randomized open-label study.
Journal of assisted reproduction and genetics2011PMID 21484319
Randomized controlled trial of different doses of metformin for ovulation induction in infertile women with polycystic ovary syndrome.
The journal of obstetrics and gynaecology research2011PMID 21518135
Metformin versus metformin plus rosiglitazone in women with polycystic ovary syndrome.
Chinese medical journal2011PMID 21518564
Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial.
JAMA2011PMID 21521847
The fixed combination of pioglitazone and metformin improves biomarkers of platelet function and chronic inflammation in type 2 diabetes patients: results from the PIOfix study.
Journal of diabetes science and technology2011PMID 21527115
A treatment strategy implementing combination therapy with sitagliptin and metformin results in superior glycaemic control versus metformin monotherapy due to a low rate of addition of antihyperglycaemic agents.
Diabetes, obesity & metabolism2011PMID 21535346
Effect of antihyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: a network meta-analysis.
Annals of internal medicine2011PMID 21576535Also indexed under metformin as a PubMed major topic
Do women with ovaries of polycystic morphology without any other features of PCOS benefit from short-term metformin co-treatment during IVF? A double-blind, placebo-controlled, randomized trial.
Human reproduction (Oxford, England)2011PMID 21593045
Metformin and exercise in type 2 diabetes: examining treatment modality interactions.
Diabetes care2011PMID 21602430
Use of metformin before and during assisted reproductive technology in non-obese young infertile women with polycystic ovary syndrome: a prospective, randomized, double-blind, multi-centre study.
Human reproduction (Oxford, England)2011PMID 21606131
Prognostic value of total testosterone for pregnancy during treatment in patients with clomiphene-citrate-resistant polycystic ovary syndrome: a pilot study.
Archives of gynecology and obstetrics2011PMID 21614496Indexed under metformin in PubMed's chemical list
Early metformin therapy (age 8-12 years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence.
The Journal of clinical endocrinology and metabolism2011PMID 21632811
Exenatide or glimepiride added to metformin on metabolic control and on insulin resistance in type 2 diabetic patients.
European journal of pharmacology2011PMID 21645507
Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial.
Breast cancer research and treatment2011PMID 21655990
Effects of metformin and rosiglitazone on peripheral insulin resistance and β-cell function in obesity: a double-blind, randomized, controlled study.
The Journal of international medical research2011PMID 21672339
A randomized, parallel group, double-blind, multicentre study comparing the efficacy and safety of Avandamet (rosiglitazone/metformin) and metformin on long-term glycaemic control and bone mineral density after 80 weeks of treatment in drug-naïve type 2 diabetes mellitus patients.
Diabetes, obesity & metabolism2011PMID 21682834
Effects of metformin in adolescents with polycystic ovary syndrome undertaking lifestyle therapy: a pilot randomized double-blind study.
Fertility and sterility2011PMID 21704212
Effects of Portulaca oleracea L. seeds in treatment of type-2 diabetes mellitus patients as adjunctive and alternative therapy.
Journal of ethnopharmacology2011PMID 21718775Compares against metformin
Alogliptin as a third oral antidiabetic drug in patients with type 2 diabetes and inadequate glycaemic control on metformin and pioglitazone: a 52-week, randomized, double-blind, active-controlled, parallel-group study.
Diabetes, obesity & metabolism2011PMID 21733058
Effect of combined metformin and oral contraceptive therapy on metabolic factors and endothelial function in overweight and obese women with polycystic ovary syndrome.
Fertility and sterility2011PMID 21733508
Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: a 12-month randomized, prospective, open- label trial.
Hepatology (Baltimore, Md.)2011PMID 21748770
Double-blind, randomized, multicentre, and active comparator controlled investigation of the effect of pioglitazone, metformin, and the combination of both on cardiovascular risk in patients with type 2 diabetes receiving stable basal insulin therapy: the PIOCOMB study.
Cardiovascular diabetology2011PMID 21756323